Atlantic Trust Group LLC cut its stake in Teleflex Incorporated (NYSE:TFX) by 1.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,568 shares of the medical technology company’s stock after selling 536 shares during the period. Atlantic Trust Group LLC owned about 0.06% of Teleflex worth $6,670,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Federated Investors Inc. PA lifted its holdings in Teleflex by 65.4% during the 2nd quarter. Federated Investors Inc. PA now owns 38,160 shares of the medical technology company’s stock worth $7,928,000 after buying an additional 15,091 shares during the last quarter. Legal & General Group Plc lifted its holdings in Teleflex by 25.6% during the 2nd quarter. Legal & General Group Plc now owns 85,403 shares of the medical technology company’s stock worth $17,734,000 after buying an additional 17,403 shares during the last quarter. Clinton Group Inc. purchased a new stake in Teleflex during the 2nd quarter worth about $325,000. Koch Industries Inc. lifted its holdings in Teleflex by 47,174.3% during the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after buying an additional 957,639 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Teleflex during the 3rd quarter worth about $955,000. Hedge funds and other institutional investors own 88.97% of the company’s stock.
TFX has been the subject of a number of recent analyst reports. Zacks Investment Research downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Thursday, August 31st. Needham & Company LLC lifted their price target on Teleflex from $228.00 to $237.00 and gave the stock a “buy” rating in a report on Tuesday, September 5th. KeyCorp reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, September 6th. Morgan Stanley raised Teleflex from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $220.00 to $274.00 in a report on Wednesday, September 6th. Finally, Leerink Swann raised Teleflex from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $227.00 to $266.00 in a report on Thursday, September 7th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $274.44.
Shares of Teleflex Incorporated (NYSE TFX) opened at $249.44 on Tuesday. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex Incorporated has a 52-week low of $157.80 and a 52-week high of $271.23. The company has a market capitalization of $11,240.00, a PE ratio of 45.03, a PEG ratio of 2.14 and a beta of 1.09.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $2.01 by $0.11. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The business had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same quarter in the previous year, the firm earned $1.80 earnings per share. The business’s revenue was up 17.3% compared to the same quarter last year. research analysts forecast that Teleflex Incorporated will post 8.35 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date of this dividend was Tuesday, November 14th. Teleflex’s dividend payout ratio (DPR) is currently 24.55%.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.